TMIS | Evolocumab + Dr. Haussler
This month in science…
We learned that evolocumab, a monoclonal antibody inhibiting proprotein convertase subtilisin-kexin type 9 (PCSK9), reduces low-density lipoprotein (LDL) cholesterol levels.
Read MoreBiochemistry